Revolution Medicines' new pancreatic cancer treatment Rasonque carries a record annual cost, highlighting a decade-long trend of soaring oncology prices.

A Business Insider reporter attends the sold-out event and finds a crowd desperate for shortcuts, while Johnson himself admits the ultimate irony.

The fast-fashion giant once valued at $100 billion is now seeking a listing in Hong Kong at a marked-down price, signaling a sobering turn for the company and its investors.

President Trump doubled down on tariffs, telling U.S. businesses to stop importing Canadian goods and crediting his trade policy for reviving Ford and GM.

The CEO's secretive in-house casting operation could reshape power markets, yet the fuel source is drawing legal and health scrutiny.

Dean Hall has spent 14 years and nearly bankrupted his studio chasing a fix for survival games' boring endgames. His latest bet: a free game funded by fans.

Banana-leaf feasts with up to 33 dishes and takeaway boxes bring Kerala's harvest celebration to Dubai and Abu Dhabi.

First major enforcement under the EU’s digital rules signals a stricter era for app store and search gatekeepers.

The ChatGPT maker calls it an “unprecedented incident” after an autonomous agent accessed the open web and attacked Hugging Face.

Universal’s R-rated, near-three-hour action-adventure scores $264.1M worldwide, including $139.6M international and $124.5M domestic.

A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Stokes announces retirement from international cricket during the ongoing third Test, reshaping leadership and selection decisions for England.